Catalyst
Slingshot members are tracking this event:
Aimmune's (AIMT) AR101 Peanut Allergy Phase 3 data to be presented February 24 at AAAAI Annual Meeting.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AIMT | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 25, 2019
Occurred Source:
http://ir.aimmune.com/news-releases/news-release-details/aimmune-therapeutics-presents-new-ar101-data-aaaai-including
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ar101, Peanut Allergy, Phase 3 Study, Aaaai Annual Meeting
